Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma (original) (raw)

• Aiba A, Chen C, Herrup K, Rosenmund C, Stevens CF, Tonegawa S . (1994a). Reduced hippocampal long-term potentiation and context-specific deficit in associative learning in mGluR1 mutant mice. Cell 79: 365–375.
  Article CAS PubMed Google Scholar
• Aiba A, Kano M, Chen C, Stanton ME, Fox GD, Herrup K et al. (1994b). Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice. Cell 79: 377–388.
  Article CAS PubMed Google Scholar
• Chen J, Kelz MB, Zeng G, Sakai N, Steffen C, Shockett PE et al. (1998). Transgenic animals with inducible, targeted gene expression in brain. Mol Pharmacol 54: 495–503.
  Article CAS PubMed Google Scholar
• Chen S, Zhu H, Wetzel WJ, Philbert MA . (1996). Spontaneous melanocytosis in transgenic mice. J Invest Dermatol 106: 1145–1151.
  Article CAS PubMed Google Scholar
• Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N et al. (1999). Essential role for oncogenic Ras in tumour maintenance. Nature 400: 468–472.
  Article CAS PubMed Google Scholar
• Chung JH, Whiteley M, Felsenfeld G . (1993). A 50 element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 74: 505–514.
  Article CAS PubMed Google Scholar
• Conn PJ, Pin JP . (1997). Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37: 205–237.
  Article CAS PubMed Google Scholar
• Conquet F, Bashir ZI, Davies CH, Daniel H, Ferraguti F, Bordi F et al. (1994). Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1. Nature 372: 237–243.
  Article CAS PubMed Google Scholar
• Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002). Mutations of the BRAF gene in human cancer. Nature 27: 949–954.
  Article Google Scholar
• Gossen M, Bujard H . (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547–5551.
  Article CAS PubMed PubMed Central Google Scholar
• Handerson T, Pawelek JM . (2003). β1,6-branced oligosaccharides and coarse vesicles: a common, pervasive phenotype in melanoma and other human cancers. Cancer Res 63: 5363–5369.
  CAS PubMed Google Scholar
• Huntington JT, Shields JM, Der CJ, Wyatt CA, Benbow U, Slingluff Jr CL et al. (2004). Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling. J Biol Chem 279: 33168–33176.
  Article CAS PubMed Google Scholar
• Karim F, Wang CC, Gereau IV RW . (2001). Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci 21: 3771–3779.
  Article CAS PubMed PubMed Central Google Scholar
• Marin YE, Namkoong J, Cohen-Solal K, Shin SS, Martino JJ, Oka M et al. (2006). Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon. Cell Signal 18: 1279–1286.
  Article CAS PubMed Google Scholar
• Marin YE, Namkoong J, Shin SS, Raines J, Degenhardt K, White E et al. (2005). Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes. Neuropharmacology 49: 70–79.
  Article CAS PubMed Google Scholar
• Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S . (1991). Sequence and expression of a metabotropic glutamate receptor. Nature 349: 760–765.
  Article CAS PubMed Google Scholar
• Michaloglou C, Vredeveld LCW, Mooi WJ, Peeper DS . (2008). BRAFE600 in benign and malignant human tumours. Oncogene 27: 877–895.
  Article CAS PubMed Google Scholar
• Nakanishi S . (1992). Molecular diversity of glutamate receptors and implications for brain function. Science 258: 597–603.
  Article CAS PubMed Google Scholar
• Nakanishi S . (1994). Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron 13: 1031–1037.
  Article CAS PubMed Google Scholar
• Nambiar S, Mirmohammadsadegh A, Doroudi R, Gustrau A, Marini A, Roeder G et al. (2005). Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays. Arch Dermatol 141: 165–173.
  Article CAS PubMed Google Scholar
• Namkoong J, Shin SS, Lee HJ, Marin YE, Wall BA, Goydos JS et al. (2007). Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res 67: 2298–2305.
  Article CAS PubMed Google Scholar
• Pollock PM, Cohen-Solal K, Sood R, Namkoong J, Martino J, Koganti A et al. (2003). Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nature Genet 4: 108–112.
  Article Google Scholar
• Rzeski W, Turski L, Ikonomidou C . (2001). Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 98: 6372–6377.
  Article CAS PubMed PubMed Central Google Scholar
• Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL et al. (2003). Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res 63: 756–759.
  CAS PubMed Google Scholar
• Sharma A, Trivedi NR, Zimmerman MA, Tuveson DA, Smith CD, Robertson GP . (2005). Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. Cancer Res 65: 2412–2421.
  Article CAS PubMed Google Scholar
• Stepulak A, Sifringer M, Rzeski W, Endesfelder S, Gratopp A, Pohl EE et al. (2005). NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci USA 102: 15605–15610.
  Article CAS PubMed PubMed Central Google Scholar
• Thandi S, Blank JL, Challiss RA . (2002). Group I metabotropic glutamate receptors, mGluR1a and mGluR5 couple to extracellular signal-regulated kinase (ERK) activation via distinct, but overlapping, signaling pathways. J Neurochem 83: 1139–1153.
  Article CAS PubMed Google Scholar
• Thomas NE . (2006). BRAF somatic mutations in malignant melanoma and melanocytic naevi. Melanoma Res 16: 97–103.
  Article CAS PubMed Google Scholar
• Van Dyke T, Jacks T . (2002). Cancer modeling in the modern era: progress and challenges. Cell 108: 135–144.
  Article CAS PubMed Google Scholar
• Wong CW, Fan YS, Chan TL, Chan AS, Ho LC, Ma TK et al. (2005). BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs. J Clin Pathol 58: 640–644.
  Article CAS PubMed PubMed Central Google Scholar